No abstract available
MeSH terms
-
Adjuvants, Immunologic / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
BCG Vaccine / therapeutic use
-
Cystectomy
-
Drug Therapy, Combination
-
Follow-Up Studies
-
France / epidemiology
-
Humans
-
Incidence
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use
-
Nephrectomy
-
Recombinant Proteins
-
Risk Factors
-
Survival Rate
-
Urinary Bladder Neoplasms / diagnosis
-
Urinary Bladder Neoplasms / therapy
-
Urologic Neoplasms / classification
-
Urologic Neoplasms / diagnosis*
-
Urologic Neoplasms / mortality
-
Urologic Neoplasms / therapy*
Substances
-
Adjuvants, Immunologic
-
Antineoplastic Agents
-
BCG Vaccine
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins